15970795

Source:http://linkedlifedata.com/resource/pubmed/id/15970795

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0025519, umls-concept:C0043031, umls-concept:C0178602, umls-concept:C1280500, umls-concept:C1707197, umls-concept:C1882417
pubmed:issue	7
pubmed:dateCreated	2005-6-22
pubmed:abstractText	To determine the in-vitro and in-vivo effects of the CYP2C9*11 polymorphism on (S)-warfarin metabolism.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/GM068769, http://linkedlifedata.com/resource/pubmed/grant/HL66682, http://linkedlifedata.com/resource/pubmed/grant/P30-ES07033, http://linkedlifedata.com/resource/pubmed/grant/RR05096
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101231005
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants, http://linkedlifedata.com/resource/pubmed/chemical/Aryl Hydrocarbon Hydroxylases, http://linkedlifedata.com/resource/pubmed/chemical/CYP2C9 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/NADPH-Ferrihemoprotein Reductase, http://linkedlifedata.com/resource/pubmed/chemical/Warfarin
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1744-6872
pubmed:author	pubmed-author:DreisbachAlbert WAW, pubmed-author:FarinFredericoF, pubmed-author:RettieAllan EAE, pubmed-author:RiederMark JMJ, pubmed-author:TaiGuoyingG, pubmed-author:VeenstraDavid LDL, pubmed-author:VerlindeChristophe L M JCL
pubmed:issnType	Print
pubmed:volume	15
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	475-81
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:15970795-Anticoagulants, pubmed-meshheading:15970795-Aryl Hydrocarbon Hydroxylases, pubmed-meshheading:15970795-Dose-Response Relationship, Drug, pubmed-meshheading:15970795-European Continental Ancestry Group, pubmed-meshheading:15970795-Female, pubmed-meshheading:15970795-Genotype, pubmed-meshheading:15970795-Humans, pubmed-meshheading:15970795-Hydroxylation, pubmed-meshheading:15970795-Japan, pubmed-meshheading:15970795-Linkage Disequilibrium, pubmed-meshheading:15970795-Male, pubmed-meshheading:15970795-Metabolic Clearance Rate, pubmed-meshheading:15970795-Middle Aged, pubmed-meshheading:15970795-Mutagenesis, Site-Directed, pubmed-meshheading:15970795-NADPH-Ferrihemoprotein Reductase, pubmed-meshheading:15970795-Polymerase Chain Reaction, pubmed-meshheading:15970795-Polymorphism, Genetic, pubmed-meshheading:15970795-Temperature, pubmed-meshheading:15970795-Warfarin
pubmed:year	2005
pubmed:articleTitle	In-vitro and in-vivo effects of the CYP2C9*11 polymorphism on warfarin metabolism and dose.
pubmed:affiliation	Department of Medicinal Chemistry, University of Washington, Seattle, WA 98195, USA.
pubmed:publicationType	Journal Article, In Vitro, Research Support, U.S. Gov't, P.H.S., Research Support, N.I.H., Extramural